Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Change in Account Payables (2021 - 2025)

Historic Change in Account Payables for MDxHealth (MDXH) over the last 4 years, with Q3 2025 value amounting to $2.8 million.

  • MDxHealth's Change in Account Payables rose 82610.97% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$904000.0, marking a year-over-year decrease of 16766.47%. This contributed to the annual value of $458000.0 for FY2024, which is 219000.0% up from last year.
  • As of Q3 2025, MDxHealth's Change in Account Payables stood at $2.8 million, which was up 82610.97% from $531905.0 recorded in Q2 2025.
  • MDxHealth's 5-year Change in Account Payables high stood at $3.1 million for Q2 2022, and its period low was -$2.6 million during Q4 2024.
  • In the last 4 years, MDxHealth's Change in Account Payables had a median value of $11000.0 in 2021 and averaged $340211.7.
  • Within the past 5 years, the most significant YoY rise in MDxHealth's Change in Account Payables was 82610.97% (2025), while the steepest drop was 82610.97% (2025).
  • Quarter analysis of 4 years shows MDxHealth's Change in Account Payables stood at $11000.0 in 2021, then surged by 27918.18% to $3.1 million in 2022, then tumbled by 183.23% to -$2.6 million in 2024, then skyrocketed by 208.42% to $2.8 million in 2025.
  • Its Change in Account Payables stands at $2.8 million for Q3 2025, versus $531905.0 for Q2 2025 and -$737000.0 for Q1 2025.